Abstract
An efficacious treatment is needed for human immunodeficiency virus (HIV)-infected and uninfected patients with progressive multifocal leukoencephalopathy (PML). To report clinical and magnetic resonance imaging changes in response to mirtazapine treatment in HIV-positive patients with PML. Case series. Outpatient neurology clinic. Four HIV-positive patients with PML. Mirtazapine use, 15 mg nightly. Neurologic examinations and cranial magnetic resonance imaging. Three patients demonstrated objective clinical improvement, and 1 patient showed improvement on magnetic resonance imaging. The patient who experienced the most significant clinical improvement was the patient who received mirtazapine therapy closest to PML symptom onset. Mirtazapine use was safe and well tolerated. Mirtazapine use may offer some benefit as treatment or prophylaxis for PML in patients with HIV infection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
